Structural requirements for SP-D function in vitro and in vivo: therapeutic potential of recombinant SP-D
Structural requirements for SP-D function in vitro and in vivo: therapeutic potential of recombinant SP-D
Surfactant protein D has multiple functions in innate immunity in the lung. The generation of SP-D knock-out mice has revealed a central role for this protein in the control of lung inflammation. Accumulating evidence in mouse models of infection and inflammation indicates that truncated recombinant forms of surfactant protein D are biologically active in vivo. This review addresses the structural requirements for recognised activities of SP-D in vitro and in vivo, with emphasis on evidence arising from studies with transgenic mice and mouse models of inflammatory lung disease. The potential of truncated recombinant forms of surfactant protein D as novel therapy for infectious and inflammatory disease is discussed.
619-31
Clark, Howard
70550b6d-3bd7-47c6-8c02-4f43f37d5213
Reid, Kenneth B.M.
74c6c3e3-d682-446d-b159-b635e6056e4e
September 2002
Clark, Howard
70550b6d-3bd7-47c6-8c02-4f43f37d5213
Reid, Kenneth B.M.
74c6c3e3-d682-446d-b159-b635e6056e4e
Clark, Howard and Reid, Kenneth B.M.
(2002)
Structural requirements for SP-D function in vitro and in vivo: therapeutic potential of recombinant SP-D.
Immunobiology, 205 (4-5), .
(doi:10.1078/0171-2985-00159).
Abstract
Surfactant protein D has multiple functions in innate immunity in the lung. The generation of SP-D knock-out mice has revealed a central role for this protein in the control of lung inflammation. Accumulating evidence in mouse models of infection and inflammation indicates that truncated recombinant forms of surfactant protein D are biologically active in vivo. This review addresses the structural requirements for recognised activities of SP-D in vitro and in vivo, with emphasis on evidence arising from studies with transgenic mice and mouse models of inflammatory lung disease. The potential of truncated recombinant forms of surfactant protein D as novel therapy for infectious and inflammatory disease is discussed.
This record has no associated files available for download.
More information
Published date: September 2002
Identifiers
Local EPrints ID: 158519
URI: http://eprints.soton.ac.uk/id/eprint/158519
ISSN: 0171-2985
PURE UUID: 9b810f3f-ddc5-409f-bdfd-9f1d64d83dba
Catalogue record
Date deposited: 08 Jul 2010 11:07
Last modified: 14 Mar 2024 01:51
Export record
Altmetrics
Contributors
Author:
Howard Clark
Author:
Kenneth B.M. Reid
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
Loading...
View more statistics